
ISSN: 2959-0574 (Print)
ISSN: 2959-0582 (Online)
CODEN: BMIAE5
CiteScore 2025: 0.7
For any inquiries regarding journal development, the peer review process, copyright matters, or other general questions, please contact the editorial office, Ms. Julia Luo, E-Mail: biofunmat@elspub.com.
For production or technical issues, please contact the production team, Mr. Jay Zhuang, E-Mail: production@elspub.com.
This study evaluates the mechanical and biological performance of Triply Periodic Minimal Surface (TPMS) scaffolds (gyroid and diamond) in two different lattice topologies (sheet and solid-based) using calcium phosphate-based materials. While natural trabecular bone exhibits a compressive strength of 20–80 MPa, current synthetic scaffolds often struggle to balance structural integrity with bioactivity. We investigated sheet and solid-based TPMS lattice topologies at porosities of 65% and 50%, manufactured using stereolithography of hydroxyapatite (HAp) and beta-tricalcium phosphate (β-TCP) slurries. Mechanical testing showed that solid-based lattice topologies provided superior performance, reaching compression strengths of up to 20 MPa, with solid-based gyroid geometries consistently outperforming diamond structures at porosities above 50%. On the other hand, sheet-based geometries offered compression strength less than 10 MPa across both HAp and TCP. Biologically, while both HAp and β-TCP supported cell proliferation and exhibited similar initial alkaline phosphatase (ALP) activity, HAp demonstrated higher structural strength at the cost of lower long-term bone mineralization. In contrast, β-TCP facilitated higher mineralization, suggesting a faster rate of biological integration. These findings indicate that while solid gyroid HAp scaffolds provide compression strength analogous to trabecular bone, the integration of β-TCP is essential for long-term osteoblast mineralisation. This research provides a framework for optimizing the trade-off between mechanical resilience and biological functionality in the design of next-generation BTE implants.
Polysaccharide materials are often called superwetting antibacterial systems because they swell or have a low initial water contact angle. But these measurements do not show that the materials kill bacteria or control biofilms. This review looks at polysaccharide-based superwetting and hydrated interfaces, including coatings, polymer brushes, porous membranes, fibrous layers, hybrid interfaces, and selected hydrogels. Hydrophilic and hydrated systems are included to help compare how these interfaces work, but their inclusion does not mean they show superwetting behavior. We assessed studies in five separate categories: quantitative wetting, interfacial hydration, bacterial adhesion, bacterial viability and biofilm response. We also examined whether wetting and biological performance persisted after exposure to proteins, salts, flow, wear and sterilization. Among the representative systems audited in this review, none reported quantitative wetting, retained wetting after relevant conditioning, and an antibacterial endpoint using matched specimens from the same preparation batch, subjected to the same conditioning protocol, and evaluated against matched controls. Hydrated polysaccharide interfaces can reduce protein adsorption and bacterial attachment. Reported bactericidal effects involved cationic groups, released drugs, metal or oxide phases, or light-activated treatment; hydration alone was not established as the cause of killing. A combined material needs two measurements: retained hydration with reduced attachment, and active killing at a reported exposure.
Microneedles, as arrayed delivery platforms composed of micron-sized needles, have attracted extensive attention in the field of transdermal drug delivery in recent years. They are capable of delivering not only small and large molecules but also therapeutic and diagnostic agents, while offering the advantage of good patient compliance. Meanwhile, microneedles also provide new ideas for the delivery of active ingredients derived from Traditional Chinese Medicine (TCM). This article comments on a recent study by Lang and Xie et al. published in Advanced Science. In this work, a metabolically stable derivative of cordycepin and its microneedle system were successfully developed, and the system exhibited potent in vivo activity in psoriasis management. By integrating structural optimization of TCM-derived compounds with microneedle delivery technology, this study offers a useful reference for the transdermal delivery of active ingredients from TCM. To further promote clinical translation, this article suggests that the mechanical strength of microneedles should be monitored as a critical quality attribute during scale-up manufacture, and that their storage stability should be systematically investigated, particularly the hygroscopic behavior of polyvinylpyrrolidone (PVP)-based microneedles and the necessity of low-humidity storage conditions.
The term biomaterial is widely used to describe materials associated with biological systems, but often fails to distinguish whether a material merely exists within a biological environment or actively participates in regulating biological processes. This ambiguity has created a subtle conceptual gap, making it difficult to distinguish passive materials from those deliberately engineered to trigger biological responses. This Editorial addresses this gap by introducing a foundational framework for defining and classifying biofunctional materials. Accordingly, biofunctional materials are defined as deliberately engineered material systems designed to engage biological environments and produce measurable and reproducible biological outcomes. To conceptualize this concept, biofunctionality is defined and described as a multidimensional continuum governed by four foundational pillars including structural, physicochemical, biological signaling, and adaptive functionality. Together, these pillars form a conceptual biofunctionality landscape, enabling materials to be interpreted according to the maturity of their functional mechanisms and the degree of integration across domains. By clarifying the distinction between passive biomaterials and actively biofunctional systems, this framework aims to provide a milestone, thereby to support clearer terminology, more rigorous evaluation, and more rational design of materials that decisively interact with living systems.